SCHEMBL7077385

SCHEMBL7077385

COc1cc(Cc2c(F)cccc2F)cc(Br)c1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
MEN1 O00255 5/20 0.56
KMT2A Q03164 5/20 0.56
MAPT P10636 5/20 0.56
GAA P10253 4/20 0.56
ALOX15 P16050 3/20 0.56
ALOX12 P18054 3/20 0.56
USP2 O75604 1/20 0.56
HSD17B10 Q99714 1/20 0.56
ALOX5 P09917 1/20 0.46
PTGS2 P35354 1/20 0.46
TP53 P04637 1/20 0.45
MAPK1 P28482 1/20 0.45
POLB P06746 1/20 0.42
KDM4E B2RXH2 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
TRPV1 Q8NER1 1/20 0.41
BLM P54132 1/20 0.41
PLEC Q15149 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7077267 0.84 CYP1A2 (0.46) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL6947629 0.79 MAPT (0.56) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL7081851 0.78 TAAR1 (0.57) ALDH1A1MEN1KMT2AGAAALOX15
SCHEMBL12766044 0.73 PTGS2 (0.60) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL14660518 0.73 ALOX5 (0.60) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL7081113 0.71 KMT2A (0.45) ALDH1A1MEN1KMT2AMAPK1
SCHEMBL10209876 0.69 ALOX5 (0.64) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL7500012 0.69 MEN1 (0.43) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL7702890 0.68 AKR1B1 (0.55) ALDH1A1KMT2AMAPTGAAALOX5
SCHEMBL1525495 0.68 GAA (0.57) ALDH1A1MEN1KMT2AMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030229079-A1 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof PAYNE LINDA S (US) 2003-12-11 US disclosed
EP-1196384-A4 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF MERCK & CO INC (US) 2002-10-23 EP disclosed
EP-1196384-A1 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF Merck & Co., Inc. (US) 2002-04-17 EP disclosed
WO-2001000578-A1 1-(AROMATIC- OR HETEROAROMATIC-SUBSTITUTED)-3-(HETEROAROMATIC SUBSTITUTED)-1,3-PROPANEDIONES AND USES THEREOF MERCK & CO., INC. (US) 2001-01-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030229079-A1 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof CYP2S1, IMPDH1, IDO1 ALDH1A1 145/4885MEN1 4377/4885KMT2A 3589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.